Terminated PHASE4 INTERVENTIONAL 2-arm NCT00961207

Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)

Sponsor: Cook County Health

Conditions Albuminuria Diabetes Macroalbuminuric Diabetic Nephropathy Microalbuminuria Proteinuria

Interventions Aliskiren

Updated 7 times since 2017 Last updated: Oct 24, 2013 Started: Aug 31, 2009 Primary completion: Jul 31, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Altitude trial which used similar drugs was terminated due to increased ADR.

A PHASE4 clinical study on Albuminuria and Diabetes, this trial is terminated or withdrawn. The trial is conducted by Cook County Health and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jul 2023 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2023 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cook County Health

Data source: Cook County Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States